O objetivo deste estudo foi avaliar in vitro a capacidade seladora de alguns materiais odontológicos em retrobturações e para tanto, utilizou-se o MTA Ângelus® Branco, MBPc, CPM® e Pasta Lysanda®, através da análise da infiltração do Enterococcus faecalis. Noventa dentes humanos unirradiculares extraídos e instrumentados, tiveram seu ápice radicular cortado num plano perpendicular ao longo eixo onde foram preparadas cavidades retrógradas com 3mm de profundidade, para selamento com os materiais em teste já relacionados. Culturas específicas de Enterococcus faecalis foram preparadas e inoculadas nos condutos radiculares dos dentes previamente fixados em aparatos especiais que tinham do lado oposto um meio de cultura estéril e específico para a bactéria em questão, separados apenas pelas retrobturações dos grupos de materiais em teste. Diariamente, o meio estéril era checado para constatar sua possível turvação; caso ocorresse demonstrava a passagem bacteriana pela retrobturação. Os quatro grupos experimentais apresentaram ao menos um espécime com infiltração bacteriana logo nas primeiras 24 horas do teste, entretanto, o número de espécimes que apresentavam turvação foi diminuindo numericamente no decorrer do período experimental, que foi de 120 dias. Os cimentos MTA Ângelus® Branco, MBPc e CPM® mostraram capacidade seladora eficaz e também comportamento semelhante entre si, pois a turvação das poucas amostras ocorreu logo nos três primeiros dias. A pasta Lysanda® apresentou o maior número de amostras infiltradas (18), em maior período de tempo. / The objective of this study was to in vitro evaluate the sealing ability of some dental retrofilling material and for that, we used the White MTA Angelus®, MBPc, CPM® cements and Lysande® paste, by examining Enterococcus faecalis infiltration. Ninety human extracted single-rooted teeth were instrumented, had their apex cut perpendicular to the long axis where the retrograde cavities were prepared with 3 mm deep, sealed with the retrofilling materials used on the study. Specific cultures of Enterococcus faecalis were prepared and inoculated into the teeths root canals previously fixed in special apparatuses that had in their opposite side a sterile type of culture specific for the bacteria in question, separated only by the retrofilling materials under test. Daily, the sterile culture was checked to verify their possible turbidity; and when there was, it demonstrated the bacterials passage by the retrofilling material. All experimental groups showed at least one specimen with bacterial infiltration in the very first 24 hour testing, however, the number of specimens that showed turbidity had decreased numerically during the trial period of 120 days. White Angelus MTA®, CPM® and MBPC cements showed effective sealing capacity and also similar behavior among themselves, because the turbidity of the few samples occurred just in the first three days. Lysanda® paste presented the greatest number of samples infiltrated (18), in a greater period of time.

O objetivo deste estudo foi avaliar in vitro a capacidade seladora de alguns materiais odontológicos em retrobturações e para tanto, utilizou-se o MTA Ângelus® Branco, MBPc, CPM® e Pasta Lysanda®, através da análise da infiltração do Enterococcus faecalis. Noventa dentes humanos unirradiculares extraídos e instrumentados, tiveram seu ápice radicular cortado num plano perpendicular ao longo eixo onde foram preparadas cavidades retrógradas com 3mm de profundidade, para selamento com os materiais em teste já relacionados. Culturas específicas de Enterococcus faecalis foram preparadas e inoculadas nos condutos radiculares dos dentes previamente fixados em aparatos especiais que tinham do lado oposto um meio de cultura estéril e específico para a bactéria em questão, separados apenas pelas retrobturações dos grupos de materiais em teste. Diariamente, o meio estéril era checado para constatar sua possível turvação; caso ocorresse demonstrava a passagem bacteriana pela retrobturação. Os quatro grupos experimentais apresentaram ao menos um espécime com infiltração bacteriana logo nas primeiras 24 horas do teste, entretanto, o número de espécimes que apresentavam turvação foi diminuindo numericamente no decorrer do período experimental, que foi de 120 dias. Os cimentos MTA Ângelus® Branco, MBPc e CPM® mostraram capacidade seladora eficaz e também comportamento semelhante entre si, pois a turvação das poucas amostras ocorreu logo nos três primeiros dias. A pasta Lysanda® apresentou o maior número de amostras infiltradas (18), em maior período de tempo. / The objective of this study was to in vitro evaluate the sealing ability of some dental retrofilling material and for that, we used the White MTA Angelus®, MBPc, CPM® cements and Lysande® paste, by examining Enterococcus faecalis infiltration. Ninety human extracted single-rooted teeth were instrumented, had their apex cut perpendicular to the long axis where the retrograde cavities were prepared with 3 mm deep, sealed with the retrofilling materials used on the study. Specific cultures of Enterococcus faecalis were prepared and inoculated into the teeths root canals previously fixed in special apparatuses that had in their opposite side a sterile type of culture specific for the bacteria in question, separated only by the retrofilling materials under test. Daily, the sterile culture was checked to verify their possible turbidity; and when there was, it demonstrated the bacterials passage by the retrofilling material. All experimental groups showed at least one specimen with bacterial infiltration in the very first 24 hour testing, however, the number of specimens that showed turbidity had decreased numerically during the trial period of 120 days. White Angelus MTA®, CPM® and MBPC cements showed effective sealing capacity and also similar behavior among themselves, because the turbidity of the few samples occurred just in the first three days. Lysanda® paste presented the greatest number of samples infiltrated (18), in a greater period of time.

Le microbiote humain est défini par l’ensemble des microbes habitant un site corporel en particulier. Les différents microbiotes de l’Homme, notamment le microbiote intestinal qui est le plus étudié, peuvent moduler de nombreux mécanismes biologiques dont le métabolisme et la réponse immunitaire. Un débalancement du microbiote au niveau des espèces qui le composent, ou dysbiose, a été associé à plusieurs maladies inflammatoires comme le diabète, l’obésité, mais aussi divers types de cancer. De plus, il a été démontré que les bactéries pouvaient avoir un impact sur la réponse des patients aux thérapies contre le cancer. Le cancer du sein est le cancer le plus mortel chez la femme. Or, l’étiologie de la maladie reste incertaine. Récemment, il a été montré que des bactéries pouvaient infiltrer les tissus plus profonds comme le tissu mammaire, formant un microbiote local. Considérant l’impact que la dysbiose peut avoir sur la réponse immunitaire antitumorale et la réponse aux traitements, nous avons émis comme hypothèse qu’une présence bactérienne intratumorale similaire, en composition et en quantité, à celle du tissu normal non-cancéreux affecte la progression du cancer du sein ainsi que le devenir clinique des patientes. La présence du microbiote intratumoral du sein a donc été validée par la détection de plusieurs composants bactériens sur des coupes tumorales à l’aide de marquages moléculaires. Puis, nous avons évalué le rôle potentiel de ce microbiote en quantifiant et identifiant les espèces bactériennes présentes dans les tumeurs et les tissus normaux adjacents des patientes de notre cohorte du cancer du sein. Nos résultats montrent une abondance moins élevée de l’ADN bactérien dans les tumeurs du sein comparativement aux tissus normaux adjacents appariés, suggérant qu’une altération du microbiote mammaire est associée au cancer. De plus, les patientes ayant un signal bactérien très faible dans leur tumeur avaient un nombre de récidives plus élevé. Cette influence de la quantité apparente de bactéries sur le devenir clinique a été observée principalement chez les patientes ayant une tumeur avancée, soit un grade ou un stade élevé, et de sous-types moléculaires Luminal HER2+, HER2+ (non-luminal) et Luminal B. Aucune relation n’a été observée entre la composition bactérienne du microbiote intratumoral mammaire et la récidive. Nos travaux suggèrent une implication pronostique et thérapeutique de la charge bactérienne du microbiote associé aux tumeurs mammaires. / The human microbiota is defined by all the microbes inhabiting a specific body site. The different human microbiota, and in particular the intestinal microbiota which is the most studied, can modulate many biological mechanisms, including metabolism and the immune response. An imbalance in the bacterial species that compose the microbiota, or dysbiosis, has been associated with several inflammatory diseases such as diabetes, obesity, but also various types of cancer. Additionally, bacteria have been shown to impact the response of patients to cancer therapy. Breast cancer is the deadliest cancer in women. However, the etiology of the disease remains uncertain. Recently, it has been shown that bacteria can infiltrate deeper tissues like breast tissue, forming a local microbiota. Considering the impact that dysbiosis can have on the anti-tumor immune response and the response to treatments, we hypothesized that an intratumoral bacterial presence similar in composition and quantity to that of normal non-cancerous tissue affects the progression of breast cancer, as well as the clinical outcomes of patients. The presence of the intratumoral breast microbiota was therefore validated by the detection of several bacterial components on whole tumor sections using molecular staining. Then, we evaluated the potential role of this microbiota by quantifying and identifying the bacterial species present in tumors and adjacent normal tissues of patients in our breast cancer cohort. Our results show a lower abundance of bacterial DNA in breast tumors compared to adjacent paired normal tissues, suggesting that an alteration of the mammary microbiota is associated with breast cancer. In addition, patients with a very low bacterial signal in their tumor had a higher number of recurrences. This influence of the apparent quantity of bacteria on the clinical outcomes has been observed mainly in patients with an advanced tumor, either a high grade or a high stage, and of the Luminal HER2+, HER2+ (non-luminal) and Luminal B molecular subtype. No relationship has been observed between the bacterial composition of the breast intratumoral microbiota and the recurrence. Our work suggests a prognostic and therapeutic implication of the bacterial load of the microbiota associated with breast tumors.

No description available.